The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.340
+0.020 (1.52%)
At close: Mar 31, 2025, 4:00 PM
1.366
+0.026 (1.96%)
After-hours: Mar 31, 2025, 6:31 PM EDT

Company Description

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.

It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.

In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers.

The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

The Beauty Health Company
The Beauty Health Company logo
Country United States
Founded 1997
Industry Household & Personal Products
Sector Consumer Staples
Employees 769
CEO Marla Beck

Contact Details

Address:
2165 Spring Street
Long Beach, California 90806
United States
Phone 800 603 4996
Website beautyhealth.com

Stock Details

Ticker Symbol SKIN
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001818093
CUSIP Number 88331L108
ISIN Number US88331L1089
Employer ID 85-1908962
SIC Code 3841

Key Executives

Name Position
Marla Malcolm Beck President, Chief Executive Officer and Director
Michael P. Monahan Chief Financial Officer
Sheri Lewis Chief Supply Chain and Operations Officer
Paul Bokota J.D. Senior Vice President and General Counsel
Carrie Caulkins Chief Marketing Officer
Celeste Ortiz Chief Human Resources Officer
Ronald Menezes Chief Revenue Officer and Executive Officer

Latest SEC Filings

Date Type Title
Mar 12, 2025 10-K Annual Report
Mar 12, 2025 8-K Current Report
Feb 28, 2025 8-K Current Report
Feb 7, 2025 SCHEDULE 13G/A Filing
Jan 31, 2025 SCHEDULE 13G Filing
Dec 17, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 10-Q Quarterly Report